Results 131 to 140 of about 2,381,535 (223)

Clinical Evaluation of Targeted Next-Generation Sequencing for Detecting Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis

open access: yes
Objective: To evaluate the clinical efficacy of targeted next-generation sequencing (NGS) technology in detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis (MTB).
Ruiying Ma, Yuanda Li, Qingbo Chen
core   +1 more source

Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB). [PDF]

open access: yesOpen Forum Infect Dis, 2022
De Castro N   +14 more
europepmc   +1 more source

Isoniazid-Resistance Conferring Mutations in Mycobacterium tuberculosis KatG: Catalase, Peroxidase, and INH-NADH Adduct Formation Activities

open access: yes, 2009
Mycobacterium tuberculosis catalase-peroxidase (KatG) is a bifunctional hemoprotein which activates isoniazid (INH), a pro-drug that is integral to frontline antituberculosis treatments.
Cade, Christine Elizabeth
core  

Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay. [PDF]

open access: yesMed J Armed Forces India, 2023
Katoch CDS   +4 more
europepmc   +1 more source

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016. [PDF]

open access: yesFront Microbiol, 2021
Tamilzhalagan S   +15 more
europepmc   +1 more source

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

open access: yes
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

Melting temperature signatures reveal occasional misclassification of low-level isoniazid resistance by Xpert MTB/XDR. [PDF]

open access: yesMicrobiol Spectr
Massou F   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy